Side-by-side financials for GANX and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GANX | NVS |
|---|---|---|
| Market cap | - | $293.70 B |
| US-listed rank | - | #46 |
| Revenue (latest FY) | $55.18K | - |
| Net income (latest FY) | -$20.16M | - |
| Net margin | -36537.0% | - |
| SEC filings | 224 | 947 |
Full pages: Gain Therapeutics, Inc. and Novartis AG, or browse the full rankings.